BACKGROUND Medication therapy management (MTM) was officially recognized by the federal government in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, which requires Medicare Part D plans that offer prescription drug coverage to establish MTM programs (MTMPs) for eligible beneficiaries. Even though the term "MTM" was first used in 2003, pharmacists have provided simil...

BACKGROUND Public health priorities can be addressed by pharmacists through channels such as medication therapy management (MTM) to optimize patient and population outcomes. However, no studies have specifically assessed pharmacists' perceptions of addressing public health priorities through MTM. OBJECTIVE The objective of this study was to assess pharmacists' opinions regarding the feasibili...

Mountaintop mining and valley fill (MTM/VF) coal extraction, practiced in the Central Appalachian region, represents a dramatic landscape-scale disturbance. MTM operations remove as much as 300 m of rock, soil, and vegetation from ridge tops to access deep coal seams and much of this material is placed in adjacent headwater streams altering landcover, drainage network, and topography. In spite ...

Objective: To determine if pharmacist-provided medication therapy management (MTM) improves medication adherence in Medicare patients. A secondary objective is to compare the total monthly cost of a patient’s prescription medication regimen 6 months before and 6 months following a comprehensive medication review (CMR). Design: Retrospective analysis of medication adherence, pre-post comparison....

Multicellular organisms use programmed cell death to eliminate unwanted or potentially harmful cells. Improper cell corpse removal can lead to autoimmune diseases. The development of interventional therapies that increase engulfment activity could represent an attractive approach to treat such diseases. Here, we describe mtm-1, the Caenorhabditis elegans homolog of human myotubularin 1, as a po...

Expanding payment for pharmacist-provided MTM services was pharmacy’s key objective, and three provisions address that issue directly. The MTM grant program, which may or may not be funded, was one. Another provision puts the congressional imprimatur on a Medicare policy decision, made in October 2009, that would marginally expand Medicare’s Part D MTM program. Still another provision opens the...

OBJECTIVE To define the natural history of X-linked myotubular myopathy (MTM). METHODS We performed a cross-sectional study that included an online survey (n = 35) and a prospective, 1-year longitudinal investigation using a phone survey (n = 33). RESULTS We ascertained data from 50 male patients with MTM and performed longitudinal assessments on 33 affected individuals. Consistent with exi...

Objective: To compare the return-on-investment (ROI) of an integrated practice model versus a "hub and spoke" practice model of pharmacist provided medication therapy management (MTM). Methods: A cohort retrospective analysis of MTM claims billed in 76 pharmacies in North Carolina in the 2010 “hub and spoke” practice model and the 2012 “integrated” practice model were analyzed to calculate the ...

BACKGROUND Patient satisfaction with medication therapy management (MTM), a required component of the Medicare Part D benefit, is an important outcome to consider when evaluating MTM programs. OBJECTIVE To measure patient satisfaction with a pharmacist-provided telephone MTM program. METHODS The study design was nonexperimental and cross sectional. A survey was mailed to Scott & White Healt...

OBJECTIVE To delineate the relationship, including similarities and differences, between medication therapy management (MTM) and contemporary pharmacist-provided services, including patient counseling, disease management, and pharmaceutical care, to facilitate the continued evolution of commonly used language and a standard of practice across geographic areas and practice environments. SUMMAR...